Synthesis of antineoplaston A10 analogs as potential antitumor agents

Archives of Pharmacal Research

Volumn 21, Issue 2, 1998, Pages 157-163

  Choi, Bo Gil ^a   Kim, Ok Young ^a   Chung, Byung Ho ^a   Cho, Won Jea ^a   Cheon, Seung Hoon ^a   Choi, Sang Un ^b   Lee, Chong Ock ^b  

^a Chonnam National University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Aniline mustards; Antineoplaston A10; Antitumor agent; Piperidinedione derivatives

Indexed keywords

3 PHENYLACETAMIDO 2,6 PIPERIDINEDIONE; ANTINEOPLASTIC AGENT; BENZENEACETAMIDE DERIVATIVE; PIPERIDONE DERIVATIVE;

ARTICLE; CELL CULTURE; CHEMISTRY; DRUG SCREENING; HUMAN; HYDROGENATION; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; BENZENEACETAMIDES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYDROGENATION; PIPERIDONES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032035387     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02974021     Document Type: Article

References (18)

1. Burzynski, S. R. and Georgiades, J., Effect of urinary peptides on DNA, RNA and protein synthesis in normal and neoplastic cells. Bed. Proc., 32, 766 (1973).
2. Burzynski, S. R., Antineoplastons: Biochemical defense against cancer. Physiol. Chem. Phys., 8, 275-279 (1976).
3. Burzynski, S. R., Mohabbat, M. O. and Burzynski, B., Toxicology studies of oral formation of antineoplaston A10 in cancer patients. Drug Exp. Clin. Res., 10, 611-619 (1984).
4. Burzynski, S. R., Synthetic antineoplastons and analogs. Drugs of the future, 11, 679 (1986).
5. Burzynski, S. R. and Kubove, E., Toxicology studies of antineoplaston A10 injections. 2nd Bien. Conf. Ind. Soc. Onc., Bombay, Feb 9-14 (1986).
6. Burzynski, S. R., Urine peptide for the treatment of Parkinson's disease. PCT Int. App. WO9204, 143 (1992).
7. De, A.U. and Pal, D., Possible antineoplastic agents I. J. Pharm. Sci., 64, 263 (1975).
8. Gravatt, G. L., Baguley, B. C., Wilson, W. R. and Denny, W. A., DNA-directed alkylating agents 6. J. Med. Chem., 37, 4338-4345 (1994).
9. Goudie, T. A., Valu, K. K., Gravatt, G. L., Boritzki, T. J., Baguley, B. C., Wilson, W. R., Woodgate, P. D. and Denny, W. A. DNA-directed alkylating agents 1. J. Med. Chem., 33, 1177-1186 (1990).
10. Hendry, L. B., Muldon, T. G., Burzynski, S. R., Copland, J. A. and Lehner, A. F., Stereochemical modelling studies of the interaction of antineoplaston A10 with DNA. Drugs Expl. Clin. Res., 13, 77 (1987).
11. Hendry, L. B., Chu, C. K. and Mahesh, V. B., WO91/ 16309, (1991).
12. Koyama, M., Takahashi, K., Chou, T.C., Darzynkiewicz, Z., Kapuscinski, J., Kelly, T. T. and Wanatabe, K.A., Intercalating agents with covalent bond forming capability. J. Med. Chem., 32, 1594-1599 (1989)
13. Lee, J. W., Choi, J. W. and Park, M. S., Synthesis and anticonvulsant evaluation of a series of N-Cbz-aminoglutarimides. Arch. Pharm. Res., 19, 248-250 (1996).
14. Niculescu-Duvaz, I., Ionescu, M., Cambanis, A., Vitan, M. and Feyns, V., Potential antitumor agents IV. Nitrogen mustards of methyl benzoic acids. J. Med. Chem., 11, 500-503 (1967).
15. Niculescu-Duvaz, I., Feyns, V., Salvaniu, M., Ionescu, M., Serban, A. and Cambanis, A., Potential antitumor agents VI. New aromatic nitrogen mustards with good antitumor activity. Bevue Roumaine de Chimie, 14, 535 (1969).
16. Rubinstein, L. V., Shoemaker, R. H., Paul, K. D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D., Monks, A., and Boyd, M. R., J. Natl. Cancer Inst., 82, 1113 (1990).
17. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J. B., Vistica, D. T., Warren, J. T., Bokesch, H., Kenny, S., and Boyd, M. R., J. Natl. Cancer Inst., 82, 1107 (1990).
18. Trual, A. G., Kisione, K. V., Theodore, J. B., Baguley, B. C., Laurence, P. G., Wilson, W. R., Paul, D. W. and Denny, W. A., DNA-directed alkylating agents: I. Structure-activity relationships for acridine-linked aniline mustards. J. Med. Chem, 33, 1177-1186 (1990).